|Up a level|
Berwick, D.C. and Calissano, M. and Corness, J.D. and Cook, S.J. and Latchman, David S. (2009) Regulation Of Brn-3a N-terminal transcriptional activity by MEK1/2-ERK1/2 signalling in neural differentiation. Brain Research 1256 , pp. 8-18. ISSN 0006-8993.
Bourke, L.T. and Knight, R,A, and Latchman, David S. and Stephanou, A. and McCormick, J. (2013) Signal transducer and activator of transcription-1 localizes to the mitochondria and modulates mitophagy. JAK-STAT 2 (4), e25666. ISSN 2162-3988.
Diss, J.K.J. and Calissano, M. and Gascoyne, D.M. and Djamgoz, M.B.A. and Latchman, David S. (2008) Identification and characterization of the promoter region of the Nav1.7 voltage-gated sodium channel gene (SCN9A). Molecular and Cellular Neuroscience 37 (3), pp. 537-547. ISSN 1044-7431.
Gandhi, S. and Wood-Kaczmar, A. and Yao, Z. and Plun-Favreau, H. and Deas, E. and Klupsch, K. and Downward, J. and Latchman, David S. and Tabrizi, S.J. and Wood, N.W. and Duchen, M.R. and Abramov, A.Y. (2009) PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death. Molecular Cell 33 (5), pp. 627-638. ISSN 1097-2765.
Gascoyne, D.M. and Dunne, J. and Behjati, S. and Sebire, N.J. and Anderson, J. and Latchman, David S. (2010) EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A. Oncogene 29 (21), pp. 3134-3145. ISSN 0950-9232.
Latchman, David S. (2013) Eukaryotic transcription factors. In: Maloy, S. and Hughes, K. (eds.) Brenner's Encyclopedia of Genetics. New York, U.S.: Elsevier, pp. 537-539. ISBN 9780080961569.
Ndisang, D. and Faulkes, D.J. and Gascoyne, D.M. and Lee, S.A. and Ripley, B.J. and Sindos, M. and Singer, A. and Budhram-Mahadeo, V. and Cason, J. and Latchman, David S. (2006) Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene 25 (1), pp. 51-60. ISSN 0950-9232.
Ndisang, D. and Lorenzato, F. and Sindos, M. and Khan, A. and Singer, A. and Latchman, David S. (2009) The HPV cellular transactivator Brn-3a can be used to predict cervical adenocarcinoma and squamous carcinoma precancer lesions in the developed and developing worlds. Obstetrics and Gynecology International , ISSN 1687-9589.
Ndisang, D. and Lorenzato, F. and Sindos, M. and Singer, A. and Latchman, David S. (2006) Detection of cervical abnormalities in a developing country using measurement of Brn-3a in cervical smears. Gynecologic Oncology 100 (1), pp. 89-94. ISSN 0090-8258.
Ripoll, V.M. and Lambrianides, A. and Pierangeli, S.S. and Poulton, K. and Ioannou, Y. and Heywood, W.E. and Mills, K. and Latchman, David S. and Isenberg, D.A. and Rahman, A. and Giles, I.P. (2014) Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome. Blood 124 (25), ISSN 0006-4971.